NLRP3 and neoplasm: NLRP3 triggers innate immunity by activating caspase-1 and then cleaves immune and metabolic substrates, especially the pro-inflammatory cytokine interleukin-1β (IL-1β), which induces inflammation and promotes tumor growth (8).